Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 0.43 USD -6.56% Market Closed
Market Cap: 144.7m USD

Wall Street
Price Targets

SGMO Price Targets Summary
Sangamo Therapeutics Inc

There are no price targets for SGMO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sangamo Therapeutics Inc Competitors:
Price Targets
CHRS
Coherus BioSciences Inc
322% Upside
BIIB
Biogen Inc
4% Upside
688177
Bio-Thera Solutions Ltd
54% Upside
EDT
Spectral Medical Inc
149% Upside
PHARM
Pharming Group NV
45% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
301207
Hualan Biological Bacterin Inc
2% Upside
4599
StemRIM Inc
179% Upside

Revenue
Forecast

Revenue Estimate
Sangamo Therapeutics Inc

For the last 13 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 14%. The projected CAGR for the next 4 years is 38%.

14%
Past Growth
38%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGMO's stock price target?
Not Available

SGMO doesn't have any price targets made by Wall Street professionals.

What is Sangamo Therapeutics Inc's Revenue forecast?
Projected CAGR
38%

For the last 13 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 14%. The projected CAGR for the next 4 years is 38%.

Back to Top